Marine Polysaccharides and Neurodegenerative Diseases
Author Information
Author(s): Zhu Lin, Ren Yuqian, Zhang Shenghan, Guo Yunliang, Zong Jinbao, Liu Yingjuan
Primary Institution: Qingdao University
Hypothesis
Can marine-derived polysaccharides serve as potential therapeutic agents against neurodegenerative diseases?
Conclusion
Marine polysaccharides, particularly fucoidan and chitosan, show promise in inhibiting neurodegenerative disease progression through various mechanisms.
Supporting Evidence
- Polysaccharides have antioxidant and anti-inflammatory properties that may help in treating neurodegenerative diseases.
- Chitosan has been shown to enhance cognitive function and memory in animal studies.
- Fucoidan can inhibit the formation of beta-amyloid, a key factor in Alzheimer's disease.
Takeaway
Marine polysaccharides from sea creatures can help protect our brain cells and might be used to treat diseases like Alzheimer's and Parkinson's.
Methodology
This review summarizes various studies on the effects of marine polysaccharides on neurodegenerative diseases.
Limitations
Much of the research is still in preclinical or early clinical stages, and more extensive human trials are needed.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website